Raul R. Rodriguez

2018

In 2018, Raul R. Rodriguez earned a total compensation of $4M as President and Chief Executive Officer at Rigel Pharmaceuticals, a 83% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$607,741
Option Awards$2,733,225
Salary$636,540
Other$3,354
Total$3,980,860

Rodriguez received $2.7M in option awards, accounting for 69% of the total pay in 2018.

Rodriguez also received $607.7K in non-equity incentive plan, $636.5K in salary and $3.4K in other compensation.

Rankings

In 2018, Raul R. Rodriguez's compensation ranked 2,802nd out of 14,244 executives tracked by ExecPay. In other words, Rodriguez earned more than 80.3% of executives.

ClassificationRankingPercentile
All
2,802
out of 14,244
80th
Division
Manufacturing
1,037
out of 5,765
82nd
Major group
Chemicals And Allied Products
355
out of 2,128
83rd
Industry group
Drugs
292
out of 1,817
84th
Industry
Pharmaceutical Preparations
224
out of 1,391
84th
Source: SEC filing on April 9, 2019.

Rodriguez's colleagues

We found five more compensation records of executives who worked with Raul R. Rodriguez at Rigel Pharmaceuticals in 2018.

2018

Dolly Vance

Rigel Pharmaceuticals

General Counsel

2018

Anne-Marie Duliege

Rigel Pharmaceuticals

Chief Medical Officer

2018

Eldon Mayer

Rigel Pharmaceuticals

Executive Vice President, Chief Commercial Officer

2018

Esteban Masuda

Rigel Pharmaceuticals

Executive Vice President, Research

2018

Dean Schorno

Rigel Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like